Most Popular Choices
Share on Facebook 19 Printer Friendly Page More Sharing Summarizing
General News      

Oops!! Mitt Romney Is Financially Invested In The Birth Control He Seeks To Restrict

Quicklink Submitted By   No comments

Amanda Lang
Message Amanda Lang
Become a Fan
  (9 fans)
an examination of Romney's financial investments reveals that the very same GOP frontrunner who is now petitioning the White House to extend the regulation's conscience clause and exclude more women from the benefits of birth control is himself invested in and profiting from pharmaceutical companies that produce the frequently prescribed and extremely common medication:
Romney's Goldman Sachs 2002 Exchange Place Fund, valued at over a million dollars in 2010, brought in nearly $600,000 in gains in 2010 and is invested in:
- Watson Pharmaceuticals: manufacturer of nine forms of emergency contraception (which Romney incorrectly identifies as "abortifacients").
- Johnson & Johnson: launched the first U.S. prescription birth control product in 1931 and produces various forms of birth control.
- Merck: produces various forms of birth control
- Mylan: produces birth control medication...
Read the rest of the story HERE:

At thinkprogress.org
Rate It | View Ratings

Amanda Lang Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

OpedNews volunteer from 2005 to 2013.

Amanda Lang was a wonderful member of the Opednews team, and the first volunteer editor, for a good number of years being a senior editor. She passed away summer 2014.

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend